Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapies. Yang X, Huang R. Leuk Res 2025;157:107924.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang X, Huang R. Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapies. Leuk Res 2025;157:107924.
PMID: 40749582